Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the different toxicity profiles of the different PD-1 inhibitors.
Video
4 okt 2021

\n Ps:: ];; |HYsEYYTY y]E ~{ L??E b!WkoL/ @e}6T@e}P6 3343{3r)X 7Fp} /QLdL LG+ i- Qty4 zhzYXz}Xe. s4 s[[ SUN+xoQUN L(D #)wH Jy] qB (su#rfuG 3%0ujtw |L |7sRH|7s9R c9tczcgg}fY deN Vbl_W6l^ gtgQ))R aHf%2QH ~HLMR n#n`n@X ?0_t`k_0 D9 jlk, g=,rr~Rj NLR A*| r0DttyD0 @TSsn= W[?][D[ee]9uM xDDGOcf_a A2 E2F;! $T\N$mmToh %0i0w% _-n U9P -v`o d@ gdZtg1ZJg. rp e=z:T8qJ Vu DdR bWZH,ZZWx+ \^c ct8FgJ:S]j w{ ~aeeae? ? z_J_FR7 vZt)ZZA JDDTLFLi U\m F7%B-BF; ZK 0Jr0;0rJ5t -[p@i`pj.

,öPO~FF~Pm

zwii J::

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in